RESMED INC — Director's Dealing 2014

Apr 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-04-21

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-21	ResMed Common Stock	M	4756	$12.468	Acquired	309746	Direct
2014-04-21	ResMed Common Stock	S	4756	$48.105	Disposed	304990	Direct
2014-04-21	ResMed Common Stock	M	70244	$21.025	Acquired	375234	Direct
2014-04-21	ResMed Common Stock	S	70244	$48.00	Disposed	304990	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-21	ResMed Common Stock Options	$12.468	M	4756	Disposed	2015-01-20	ResMed Common Stock (4756)	Direct
2014-04-21	ResMed Common Stock Options	$21.025	M	70244	Disposed	2014-11-07	ResMed Common Stock (70244)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	200000	Indirect
ResMed Common Stock	200000	Indirect

Footnotes

F1: This transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/3 per year on the anniversary of the grant.

F3: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F4: This transaction was executed in multiple trades at prices ranging from $48.07 to $48.21. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.